WWWenxue Wang

Wenxue Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Wenxue Wang has a total of 37 co-authors. Here are the top co-authors by number of shared publications:

  • Jiawei Geng

    Faculty of Life Science and Technology, Kunming University of Science and Technology, Kunming, Yunnan, China.

    10 shared publications
  • Huijie Zhong

    Department of Infectious Disease and Hepatic Disease, The First People’s Hospital of Yunnan Province

    4 shared publications
  • Zhongjian Liu

    Institute of Basic and Clinical Medicine, First People’s Hospital of Yunnan Province, Affiliated Hospital of Kunming University of Science and Technology, Kunming, Yunnan, China

    4 shared publications
  • Yumeng Gan

    Department of Infectious Disease and Hepatic Disease, The Affiliated Hospital of Kunming University of Science and Technology, The First People’s Hospital of Yunnan Province, Kunming, Yunnan, China

    3 shared publications
  • Fan Zhang

    Department of Gastroenterology, Third People’s Hospital of Yunnan Province, Kunming, China

    2 shared publications
  • Jieyu Liu

    Department of Gastroenterology, Third People's Hospital of Yunnan Province, Kunming, Yunnan, China

    2 shared publications

Latest Publications

  • Open Access

    Identification of circadian rhythm-associated key genes in metabolic dysfunction-associated fatty liver disease

    by Jinbo Luo, Xiuying Ma, Quanyu Wang, Ruyi Zhang, Ling Zhu, Xue Feng, Wenxue Wang, Jiawei Geng

    As of now, current studies have confirmed that circadian rhythm genes (CRGs) can modulate the onset and development of metabolic dysfunction-associated fatty liver disease (MAFLD). Leveraging computational biology methodologies, systematic and thorough investigations into MAFLD and CRGs enhance our capacity to gain deeper insights into the disease's pathogenic mechanisms. MAFLD-associated datasets (GSE89632 and GSE126848) and 248 circadian rhythm genes genes (CRGs) were analyzed. Principal component analysis (PCA) was performed on the GSE89632 dataset, and samples were divided into training and test sets. Differentially expressed genes (DEGs) from the training set were intersected with key module genes from WGCNA to identify intersection genes. These were then analyzed for expression consistency across datasets, followed by machine learning to identify key genes. Further analyses, including nomogram development, gene set enrichment analysis (GSEA), immune infiltration, and drug prediction, were also conducted. Four outliers were excluded, leaving 17 MAFLD and 22 control samples for analysis. 141 intersection genes were identified, with 36 showing consistent expression trends. Machine learning identified SOCS2, FBXO27, and HMMR as key genes. A nomogram based on these genes predicted MAFLD patient survival. GSEA revealed significant enrichment in pathways like olfactory transduction and peroxisome. Mast cell activation correlated strongly with SOCS2 and FBXO27. SOCS2, FBXO27, and HMMR are identified as key genes in MAFLD, providing new insights into the disease mechanisms.

  • Open Access

    Enteric nervous system in microbiota-associated gut inflammation

    by Cen Yang, Xuping Lan, Huijie Zhong, Jiawei Geng, Wenxue Wang

    The enteric nervous system (ENS), a distinctive and intricate compartment of the peripheral nervous system (PNS), is characterized by its capacity to autonomously coordinate fundamental gut functions independent of central nervous system (CNS) input. Comprising vast, densely packed networks of neurons and glial cells distributed throughout the intestinal wall, the ENS not only directly governs motility, secretion, and absorption but also engages in dynamic crosstalk with intestinal immune cells to establish immune defense barriers and fine-tune inflammatory responses. This system is persistently exposed to and deeply engaged with a dynamic microenvironment shaped by both external (e.g., microbiota and their metabolites) and internal (e.g., immune cells, stromal cells) signals. The gut microbiota and its metabolic products play pivotal roles in maintaining mucosal barrier integrity and orchestrating the progression of intestinal inflammation. They influence the development and repair of enteric neurons and can directly participate in disease pathogenesis or exert their effects through immune-mediated mechanisms. This review delves into the complex interplay between the ENS and the gut microbiota within the context of intestinal inflammation pathogenesis.


  • Open Access

    Microbial genotoxin-elicited host DNA mutations related to mitochondrial dysfunction, a momentous contributor for colorectal carcinogenesis

    by Xue Yang, Yumeng Gan, Yuting Zhang, Zhongjian Liu, Jiawei Geng, Wenxue Wang

    Gut microbe dysbiosis increases repetitive inflammatory responses, leading to an increase in the incidence of colorectal cancer. Recent studies have revealed that specific microbial species directly instigate mutations in the host nucleus DNA, thereby accelerating the progression of colorectal cancer. Given the well-established role of mitochondrial dysfunction in promoting colorectal cancer, it is reasonable to postulate that gut microbes may induce mitochondrial gene mutations, thereby inducing mitochondrial dysfunction. In this review, we focus on gut microbial genotoxins and their known and potential targets in mitochondrial genes. Consequently, we propose that targeted disruption of genotoxin transport pathways may effectively reduce the rate of mitochondrial gene mutations and yield substantial benefits for the prevention of colorectal carcinogenesis.


  • Open Access

    Gut microbes in central nervous system development and related disorders

    by Yumeng Gan, Yao Chen, Huijie Zhong, Zhuo Liu, Jiawei Geng, Huishan Wang, Wenxue Wang

    The association between gut microbiota and central nervous system (CNS) development has garnered significant research attention in recent years. Evidence suggests bidirectional communication between the CNS and gut microbiota through the brain-gut axis. As a long and complex process, CNS development is highly susceptible to both endogenous and exogenous factors. The gut microbiota impacts the CNS by regulating neurogenesis, myelination, glial cell function, synaptic pruning, and blood-brain barrier permeability, with implication in various CNS disorders. This review outlines the relationship between gut microbiota and stages of CNS development (prenatal and postnatal), emphasizing the integral role of gut microbes. Furthermore, the review explores the implications of gut microbiota in neurodevelopmental disorders, such as autism spectrum disorder, Rett syndrome, and Angelman syndrome, offering insights into early detection, prompt intervention, and innovative treatments.


  • Open Access

    Corrigendum: Diversity recovery and probiotic shift of gastric microbiota in functional dyspepsia patients after Helicobacter pylori eradication therapy

    by Wenxue Wang, Zhongjian Liu, Yu Zhang, Zhiping Guo, Jieyu Liu, Siyun Li, Jihua Huang, Jiawei Geng, Fan Zhang, Qiang Guo

    Corrigendum: Diversity recovery and probiotic shift of gastric microbiota in functional dyspepsia patients after Helicobacter pylori eradication therapy

  • Open Access

    Gut microbe and hepatic macrophage polarization in non-alcoholic fatty liver disease

    by Yao Chen, Yumeng Gan, Huijie Zhong, Yincong Liu, Jingdi Huang, Wenxue Wang, Jiawei Geng

    Non-alcoholic fatty liver disease (NAFLD) is a common chronic hepatic disorder with the potential to progress to hepatic fibrosis, hepatic cirrhosis, and even hepatocellular carcinoma. Activation of hepatic macrophages, important innate immune cells predominantly composed of Kupffer cells, plays a pivotal role in NAFLD initiation and progression. Recent findings have underscored the regulatory role of microbes in both local and distal immune responses, including in the liver, emphasizing their contribution to NAFLD initiation and progression. Key studies have further revealed that gut microbes can penetrate the intestinal mucosa and translocate to the liver, thereby directly influencing hepatic macrophage polarization and NAFLD progression. In this review, we discuss recent evidence regarding the translocation of intestinal microbes into the liver, as well as their impact on hepatic macrophage polarization and associated cellular and molecular signaling pathways. Additionally, we summarize the potential mechanisms by which translocated microbes may activate hepatic macrophages and accelerate NAFLD progression.


  • Open Access

    Diversity recovery and probiotic shift of gastric microbiota in functional dyspepsia patients after Helicobacter pylori eradication therapy

    by Wenxue Wang, Zhongjian Liu, Yu Zhang, Zhiping Guo, Jieyu Liu, Siyun Li, Jihua Huang, Jiawei Geng, Fan Zhang, Qiang Guo

    The effects of Helicobacter pylori eradication on gastric mucosa-colonizing microbes in patients with functional dyspepsia (FD) remain unclear. Here, we explored microbial variation induced by H. pylori infection and eradication treatment in FD patients. Gastric microbial abundance and diversity were significantly reduced in the H. pylori-infected FD patients. Eradication treatment increased alpha and beta diversity of gastric mucosa-colonizing microbes, and promoted the expansion of several probiotic microbes, such as Leuconostoc mesenteroides, which exhibited a matched antagonistic performance against H. pylori. Significant variation was observed in gastric mucosa-colonizing microbes between H. pylori-positive and H. pylori-negative FD patients. Eradication treatment induced microbial diversity recovery and may provide sufficient nutrition and space for probiotic microbes, such as Leuconostoc mesenteroides.


  • Open Access

    Correlation analysis of lung mucosa-colonizing bacteria with clinical features reveals metastasis-associated bacterial community structure in non-small cell lung cancer patients

    by Wenxue Wang, Xiao Liang, Hui Kong, Yun Yang, Yilan Xia, Qiongjiao Wang, Andong Xia, Jiawei Geng

    Background: Microbes colonizing lower airways can regulate the host immune profile and consequently participate in lung disease. Increasing evidence indicate that individual microbes promote lung cancer progression and are involved in metastasis incidence. To date, however, no study has revealed the community structure of lung bacteria in metastatic non-small cell lung cancer (NSCLC) patients. Methods: We prospectively enrolled 50 healthy subjects and 57 NSCLC patients. All healthy subjects and NSCLC patients underwent bronchoscope procedures for brush specimen collection. The 16 S ribosomal RNA gene was sequenced to characterize the community structure of lung mucosa-colonizing bacteria. The peripheral blood of NSCLC patients was also measured for leukocytes and cancer markers. Results: The lung bacteria of healthy subjects and NSCLC patients were divided into four communities. All community 2 members showed increased abundance in NSCLC patients compared with healthy subjects, and most community 2 members showed increased abundance in the metastatic NSCLC patients compared with the non-metastatic group. These bacteria were significantly and positively correlated with eosinophils, neutrophils and monocytes in the metastatic NSCLC group. In addition, the correlation between lung bacteria and cancer markers differed between the metastatic and non-metastatic NSCLC patients. Furthermore, bronchoalveolar lavage fluid from lung adenocarcinoma patients directly promoted NSCLC cell migration. Conclusions: The community structure of lung mucosa-colonizing bacteria was relatively stable, but changed from the healthy population to NSCLC patients, especially the metastatic group. This distinct community structure and specific correlation with immune cells and cancer markers could help to distinguish NSCLC patients with or without metastasis.


  • Open Access

    Prospect of research hotspots in prevention and treatment of diseases based on intestinal microbiome

    by Yue Cai, Yuting Zhang, Wenxue Wang, Jiawei Geng

    With the in-depth study of gut microbiota, the methods of preventing and treating diseases have gradually diversified. But there is still lack of precise therapies methods to better treat the diseases. Therefore, researcher must focus on how to accurately regulate gut microbiota to achieve it. In order to promote the rapid development of this field, we provide several insights in gut microbiome-based precision therapies while prospecting the future directions.


  • Open Access

    Mucosa-Colonizing Microbiota Correlate With Host Autophagy Signaling in Patients With Inflammatory Bowel Disease

    by Wenxue Wang, Zhongjian Liu, Wei Yue, Ling Zhu, Huijie Zhong, Chao Yang, Tian He, Ping Wan, Jiawei Geng

    Both bacteria and autophagy are implicated in inflammatory bowel disease (IBD) pathogenesis. However, how bacteria crosstalk with autophagy signaling remains largely known, especially in intestinal mucosa. This study aimed to profile the internal complex autophagy signaling cascade and their external correlation with these bacteria, and consequently provide a systematic and precise target for future IBD diagnosis and therapy. We found the Ulcerative colitis (UC) patients exhibited more severe dysbiosis than the Crohn’s disease (CD) patients, as represented by alpha diversity, community phenotypes, and functional annotation compared with the control population. Meanwhile, CD patients showed greater transcriptional signaling activities of autophagy, endoplasmic reticulum (ER) stress, and bile acid production. Dominant bacteria (e.g., Rhodococcus, Escherichia, Shigella, and Enterococcus) were positively correlated and low-abundance bacteria (e.g., Bacillus, Acidovorax, Acinetobacter, and Stenotrophomonas) were negatively correlated with the autophagy signaling cascade (184 autophagy genes, 52 ER stress genes, and 22 bile acid production genes). Our observations suggested UC patients showed temporary and widespread microbiota turbulence and CD patients showed processive and local autophagy activity during IBD progression. Intestinal mucosa-colonizing bacteria were correlated with the bile/ER stress/autophagy signaling axis in IBD pathogenesis.